Lack of SH3 domain does not imply a more severe clinical course in Ph+ chronic myeloid leukemia patients
Open Access
- 15 June 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 95 (12), 4019-4020
- https://doi.org/10.1182/blood.v95.12.4019
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Concamitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patientLeukemia, 1999
- A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL geneLeukemia, 1998
- The SH3 Domain Contributes to BCR/ABL-Dependent Leukemogenesis In Vivo: Role in Adhesion, Invasion, and HomingBlood, 1998
- A novel 203 kD aberrant BCR‐ABL product in a girl with Philadelphia chromosome positive acute lymphoblastic leultaemiaBritish Journal of Haematology, 1993